The number of breast cancer surgery which a hospital performs yearly does not play a significant role in the chance of survival. This is the conclusion of research of Sabine Siesling from the University of ...
Aug 20, 2014
not rated yet | 0
Just a week after the controversy over breast cancer drug Kadcyla, the inflexibilities within the UK's disparate drug approval systems have been pulled into sharp focus once again.
Aug 18, 2014
5 / 5 (1) | 0